经皮椎间盘摘出联合医用臭氧治疗腰椎间盘突出症

目的探讨经皮髓核摘除术(PLD)联合医用臭氧注射治疗腰椎间盘突出症的临床效果及可行性。方法临床与影像检查确诊为腰椎间盘突出25例,先行PLD,后行椎间盘内及椎旁注射臭氧。结果25例病人治疗后经一年随访,治愈21例,有效24例,无效1例,无一例并发症。结论PLD联合医用臭氧治疗腰椎间盘突出症,安全可靠,可改善治疗效果,减少不良反应,值得推广应用。     

医学生抑郁情绪与家庭及生活事件的相关性研究

目的 探讨医学专业大学生抑郁情绪与家庭及生活事件的相关性，为早期干预提供科学理论依据。方法 采用自拟量表对482名医学专业在校大学生调查，并做影响因素分析。结果 大学生无抑郁或极轻微192人占39．8％；轻度209人占43．4％；中度58人占12％；重度23人占4．8％。生源地、父亲文化程度、专业满意度、人际关系的敏感、学习压力的大小、丧失因子、受惩罚因子和健康适应因子对大学生抑郁情绪的产生有显著影响，而性别、家庭类型和经济情况对医学专业大学生抑郁情绪产生关系不大（P〉0．05）。结论 要重视学生中存在的抑郁情绪问题，采取积极有效措施帮助学生消除抑郁情绪。     

减少急诊医疗纠纷实行全程无缝隙优质服务

目的防范医疗纠纷,提供“全程无缝隙优质服务”,以提高急诊护理急救服务质量。方法对急诊33 700例急症病人采用热情接诊、主动护送(护送病人检查和转入病区)、细心观察、真实记录、送走道别等服务措施。结果共紧急护送急症患者33 700例(100%);在护送过程中发生病情变化者117例(0.35%),经急救处理全部脱险;医疗纠纷发生率为0。结论采用“全程无缝隙优质服务”,可减少急诊科医疗纠纷的发生,提高医疗质量。     

我国医疗器械数字化技术发展中存在的主要问题及原因

本文提出了我国医疗器械产业中数字化技术发展中存在的主要问题，并分析了问题产生的原因。     

Proposed new bladder volume monitoring device based on impedance measurement

A new implantable bladder volume-monitoring device based on the impedance measurement of the detrusor muscle is described. The system is completely autonomous and forms a mixed-signal (analogue/digital) feedback loop with a neuro-stimulator to rectify bladder dysfunctions (incontinence and retention) through neuromuscular stimulation techniques. A programmable instrumentation amplifier and a signal processing block, to eliminate the artefacts caused by the patient’s movements, have been designed and tested. The layout for the signal processing block has been realised in 0.8 μm BiCMOS technology.     

带手套穿刺对留置套管针一次成功率的影响

为探讨戴手套与不戴手套穿刺对留置静脉套管针一次成功率的影响 ,为护理人员的自身防护提供科学依据 ,选取冠状动脉搭桥术病人 12 0例 ,随机分为实验组和对照组 ,实验组采用戴手套穿刺法 ,对照组采用常规洗手后不戴手套穿刺法。结果两组一次穿刺成功率经χ2 检验 ,无统计学意义( χ2 =0 .5 6 3,P >0 .0 5 )。说明戴手套留置套管针并不影响一次穿刺成功率。     

便携式负压吸引装置的设计及材料学特点

对负压吸引装置便携方式的研究一直是急救医学追求的目标之一，因为它能够极大地促进急救成功率。文章基于这种需要，研制了一套便携式负压吸引装置，并根据实际应用效果，选择优化的制造材料。研制的便携式负压吸引装置主要由特殊设计的储液罐及罐盖、负压产生装置、过渡接头等部分组成，关键部件采用特殊材料制作，体积小，质量轻，操作简单，易于携带，完全能满足临床抢救及治疗的需要。作为一种急救中必不可少的器械，便携式负压吸引装置在急救伤病员运输、转运，家庭急救，及无动力源环境等情况下，对于抢救患者及提高救治效果，具有极大的竞争优势和应用前景。     

FDA’S Perspectives on Cardiovascular Devices

The Food and Drug Administration (FDA) decision process for approving or clearing medical devices is often determined by a review of robust clinical data and extensive preclinical testing of the device. The mission statement for the Center for Devices and Radiological Health (CDRH) is to review the information provided by manufacturers so that it can promote and protect the health of the public by ensuring the safety and effectiveness of medical devices deemed appropriate for human use (Food, Drug & Cosmetic Act, §903(b)(1, 2(C)), December 31, 2004; accessed December 17, 2008 ). For high-risk devices, such as ventricular assist devices (VADs), mechanical heart valves, stents, cardiac resynchronization therapy (CRT) devices, pacemakers, and defibrillators, the determination is based on FDA’s review of extensive preclinical bench and animal testing followed by use of the device in a clinical trial in humans. These clinical trials allow the manufacturer to evaluate a device in the intended use population. FDA reviews the data from the clinical trial to determine if the device performed as predicted and the clinical benefits outweigh the risks. This article reviews the regulatory framework for different marketing applications related to cardiovascular devices and describes the process of obtaining approval to study a cardiovascular device in a U.S. clinical trial.     

Crediting his critics' concerns: Remaking John Snow's map of Broad Street cholera, 1854

Few cases in the history of epidemiology and public health are more famous than John Snow's investigation of a neighborhood cholera outbreak in the St. James, Westminster, area of London in 1854. In this study Snow is assumed to have proven that cholera was water rather than airborne through a methodology that became, and to a great extent remains, central to the science and social science of disease studies. And yet, Snow's work did not satisfy most of his contemporaries who considered his proof of a solely waterborne cholera interesting but unconvincing. Uniquely, this paper asks whether the caution of Snow's contemporaries was reasonable, and secondly, whether Snow might have been more convincing within the science of the day. The answers significantly alter our understanding of this paradigmatic case. It does so in a manner offering insights both into the origins of nineteenth century disease analysis and more generally, the relation of mapping in the investigation of an outbreak of uncertain origin. The result has general relevance—pedagogically and practically—in epidemiology, medical geography, and public health.